Skip to main content
. 2020 Nov 24;39(1):81–97. doi: 10.1007/s40273-020-00986-4

Table 1.

Inclusion and exclusion criteria

Category Inclusion criteria Exclusion criteria
Intervention/comparator Intervention or comparator is a drug

No drug evaluated

Health policy programs evaluated

Outcomes

Presenteeism

Absenteeism

Time off/days off/sick leave

Loss of employment

Productivity loss associated with premature mortality

No relevant cost element incorporated in cost assessment
Study types

Cost-effectiveness analyses

Cost-utility analyses

Not original research study (e.g., reviews, commentaries, and editorials)

Health economic assessment other than a cost-effectiveness analyses/cost-utility analyses

Language English (full text version) Full text in language other than English
Time period Studies published in or after 2010 Studies published before 2010 were excluded to ensure that we only include the most recent studies